In the News | Charles River
   
 
 
   
   

How to Ensure the Best Chance of Success for Your Therapeutic Proteins Program
Life Science Leader – November 5, 2009

The exciting field of biotechnology-derived therapeutic proteins, or biologics, has the potential to yield important medical breakthroughs in just about every branch of medicine. However, due to the size and complexity of these unique therapeutic proteins, the process for safely overcoming regulatory hurdles and bringing a biologic to market is vastly different from the processes for any other type of pharmaceutical. This problem is compounded due to the fact that the drug development process for individual biologics also differ greatly from each other and that no clear regulatory guidance exists for each type of biologics...Read the full article.

   
Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
May 14 - New Models for Evaluating COPD or ...
May 11 - Expert Safety Testing to Accelerat...
Jun 17-Jun 20 -  Noordwijk aan Zee, the Netherlands - 19th MDO Meeting / 12th European ...
Jun 02-Jun 05 - Vancouver, British Columbia - CALAS
Jun 05-Jun 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Biol...
Jun 05-Jun 08 - Saint Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Scientist I Wilmington, MA
Manager International Tax Wilmington, MA

Charles River Laboratories, Inc.